BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 7, 2006
View Archived Issues
MGI Sells Dacogen Rights Ex-North America To Cilag
Two months after receiving FDA approval for Dacogen to treat myelodysplastic syndromes, MGI Pharma Inc. licensed rights to the drug outside North America to Cilag GmbH. (BioWorld Today)
Read More
Alnylam's Amended Merck Deal Worth Up To $120M In Payments
Read More
Tethers, Combination Therapy Suggest T-Cell Use In Cancer
Read More
Valera Seeking Approval For Annual Implant To Fight CPP
Read More
Ambrx's Series C Adds $52M To Advance Lead Candidates
Read More
Clinic Roundup
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More